6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride

6-(4-(4-(2,3-dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one hydrochloride
Trade Name
Orphan Indication Pulmonary Arterial Hypertension
USA Market Approval USA
USA Designation Date 2016-11-09 00:00:00
Sponsor Reviva Pharmaceuticals, Inc.;3900 Freedom Circle, Suite 101;Santa Clara, California, 95054